SALIS, BARBARA
 Distribuzione geografica
Continente #
NA - Nord America 168
EU - Europa 140
AS - Asia 39
AF - Africa 3
Totale 350
Nazione #
US - Stati Uniti d'America 164
DE - Germania 69
IT - Italia 31
CN - Cina 19
GB - Regno Unito 9
FR - Francia 7
RU - Federazione Russa 7
NL - Olanda 5
TW - Taiwan 5
CA - Canada 4
IN - India 4
UA - Ucraina 4
VN - Vietnam 4
RO - Romania 3
ZA - Sudafrica 3
CZ - Repubblica Ceca 2
HK - Hong Kong 2
KR - Corea 2
ES - Italia 1
FI - Finlandia 1
LK - Sri Lanka 1
PH - Filippine 1
PT - Portogallo 1
SA - Arabia Saudita 1
Totale 350
Città #
Fairfield 27
Ashburn 21
Cambridge 16
Woodbridge 14
Buffalo 12
Beijing 9
Trieste 9
Houston 8
Leawood 7
Nürnberg 7
Seattle 7
Taipei 5
Council Bluffs 4
Dong Ket 4
Milan 4
Santa Cruz 4
Ann Arbor 3
Muizenberg 3
Wilmington 3
Boardman 2
Central 2
Chicago 2
Genoa 2
London 2
Los Angeles 2
Strasbourg 2
Venice 2
Wuhan 2
Amsterdam 1
Azzano Decimo 1
Bengaluru 1
Columbus 1
Costa Mesa 1
Des Moines 1
Draveil 1
Esslingen am Neckar 1
Fremont 1
Gattaran 1
Helsinki 1
Jeddah 1
Lake Forest 1
Las Vegas 1
Livorno 1
Milpitas 1
Montréal 1
Mountain View 1
Nuremberg 1
Ottawa 1
Paris 1
Phoenix 1
Provo 1
Rome 1
San Diego 1
San Mateo 1
Shanghai 1
Siena 1
Southend 1
University Park 1
Varedo 1
Yongin-si 1
Totale 217
Nome #
Polymer-mediated delivery of siRNAs to hepatocellular carcinoma: Variables affecting specificity and effectiveness, file e2913fdc-3838-f688-e053-3705fe0a67e0 271
STARD3 and the identification of new cholesterol transport inhibitor, file e2913fde-630e-f688-e053-3705fe0a67e0 47
Liposomal delivery of a Pin1 inhibitor complexed with cyclodextrins as new therapy for high-grade serous ovarian cancer, file e2913fdf-80a1-f688-e053-3705fe0a67e0 31
First-of-its-kind STARD 3 Inhibitor: In Silico Identification and Biological Evaluation as Anticancer Agent, file e2913fdc-c3bb-f688-e053-3705fe0a67e0 3
Strategies to optimize siRNA delivery to hepatocellular carcinoma cells, file e2913fdb-5870-f688-e053-3705fe0a67e0 2
Liposomal delivery of a Pin1 inhibitor complexed with cyclodextrins as new therapy for high-grade serous ovarian cancer, file e2913fdd-90c9-f688-e053-3705fe0a67e0 2
First-of-its-kind STARD 3 Inhibitor: In Silico Identification and Biological Evaluation as Anticancer Agent, file e2913fdc-c3bf-f688-e053-3705fe0a67e0 1
Totale 357
Categoria #
all - tutte 697
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 697


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201917 0 0 0 0 0 0 0 0 0 0 10 7
2019/2020120 5 14 8 18 11 10 11 14 13 5 7 4
2020/202161 4 7 1 2 10 7 8 2 5 5 7 3
2021/202250 6 5 6 4 3 4 2 5 1 3 11 0
2022/202336 2 4 6 5 3 1 2 1 1 2 6 3
2023/202457 2 0 7 5 4 16 5 7 5 2 4 0
Totale 357